SCHEMBL9702817

SCHEMBL9702817

CC(C)=CCCCC(P(=O)(O)O)P(=O)(O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9633712 0.92 FDPS (0.57) FDPS
Sq-34919 SCHEMBL9632781 0.89
Sq-34919 SCHEMBL9633342 0.89
Sq-34919 SCHEMBL9632769 0.89
SCHEMBL9631973 0.89
SCHEMBL9631967 0.89
SCHEMBL839903 0.86 FDPS (0.52) FDPS
SCHEMBL9633372 0.84
SCHEMBL9632034 0.84
SCHEMBL9632023 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0513760-A2 Use of biphosphonate squalene synthetase inhibitors in pharmaceutical compositions useful in lowering cholesterol E.R. SQUIBB & SONS, INC. (US) 1992-11-19 EP claimed
EP-0513760-A2 Use of biphosphonate squalene synthetase inhibitors in pharmaceutical compositions useful in lowering cholesterol E.R. SQUIBB & SONS, INC. (US) 1992-11-19 EP disclosed